HomeOpen Access News

Open Access News

Pioneering quantum biology and medicine with the $21 Million Berggren Center

The University of Chicago has received a $21 million gift from philanthropist Thea Berggren to establish the Berggren Center for Quantum Biology and Medicine. This groundbreaking center will merge quantum engineering with biology to revolutionise medicine, aiming to unlock new insights for diagnostics and therapies.

What does the Budget have in store for the pension industry?

Andrew Megson, Executive Chairman, My Pension Expert, discusses what the pension industry hopes to see from the Budget 2021 and explains what the touted changes could mean for UK savers.

Scientists calculate the impact of wildfires on global ecosystems

After going through decades' worth of data, scientists at the University of Cambridge explain the impact of wildfires on global ecosystems - from carbon dioxide emissions to the resilience of trees.

Saving Earth’s biodiversity through a story revolution

The WILD Foundation’s President, Vance Martin and Vice President of Policy and Communications, Amy Lewis, highlight the important and often forgotten role of storytelling and community organising to encourage conservation.

Only 1% of people flying to the UK are going to a quarantine hotel

The Home Affairs Committee Chair Yvette Cooper found that 1% of the 15,000 people flying to the UK daily are being processed through the quarantine hotel system.

The Pfizer vaccine is stopping 92% of severe COVID cases in Israel

Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.

Horizon Europe: EU research & innovation

Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, describes Horizon Europe and scaling up high-impact and breakthrough research & innovation.

COVID-19 and diabetes telehealth

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.

Sterilair PRO – Biological air treatment

Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.

REACT study: UK vaccine hesitancy is the highest in London

New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.

What support is available to businesses not eligible for new lockdown grants?

Michael Foote, Director of Quote Goat, discusses what financial support is available for businesses that aren't eligible for the government's new lockdown grants, including the Self Employed Income Support Scheme.

How technology can transform the elective care challenge

Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.

Horizon Europe launches €619 million Starting Grants for researchers

The first Horizon Europe grants will be launched today (25 February), with Starting Grants for researchers worth €619 million available.

The Californian COVID mutation is more infectious

The Californian COVID mutation appears to be as infectious as the UK or South African mutations - but does it have the potential to be more deadly?

42% of people on disability allowance live in poverty

The Social Market Foundation report found that 42% of families who rely on disability allowance are simultaneously living in poverty.

Towards an energy transition

Neil Gordon, Chief Executive of Subsea UK, charts the move towards energy transition, green energy and the ultimate goal of net-zero, including comment on the burgeoning Asia-Pacific market.

FDA reveals that Johnson & Johnson vaccine is 86% effective

New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders